views: 0

Cai Gengqian

Department of Quantitative Sciences, GlaxoSmithKline, King of Prussia, PA 19406, USA. gengqian.2.cai@gsk.com

Sign in to view more

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers3 papers

Sort

By YearBy Citation

Operating characteristics of a partial-block randomized crossover bioequivalence study for dutasteride, a drug with a long half-life: investigation through simulation and comparison with final results.

Gengqian Cai,Jake J Thiessen,Charlotte A Baidoo,Michael J Fossler

Journal of clinical pharmacology, no. 10 (2010): 1142-1150

Cited by1WOSBibtex

Abstract 16936: Inhibition of p38 Mitogen-Activated Protein Kinase Attenuates Vascular and Systemic Inflammation in Patients with Atherosclerosis as Assessed by 18-F Fluorodeoxyglucose PET-CT

Maysoon Elkhawad,J H Rudd,Lea Sarovblat,Michael S Marber,Robin P Choudhury, L Davies,D J Collier,Gengqian Cai,Robert N Willette,F V Gleeson,John J Lepore,Bill Davis

Circulation, (2010)

Cited by5Bibtex

Abstract 5469: PPAR{delta} Agonist Decreases Inflammatory Burden of Abdominal Fat by Reducing Adipose Macrophage Levels and Chemotaxis in Humans

Lea Sarov-Blat, Barbara Kozac, Lisa Cass,Gengqian Cai,Jeffrey M. Gimble,Dennis L. Sprecher,Steven M. Smith

Circulation, (2008)

Bibtex

View All

Base Info Papers Patents Projects